Promise Bio

Transforming immune-mediated disease treatment with advanced precision medicine solutions using epiproteomics and AI.

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo, Israel Founded 2023
Last updated 2026-07-26
Total raised
$9.0M
Last: Undisclosed Round 2024-12
Stage
Seed
Founded
2023
Headcount
14
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

Promise Bio is a precision medicine company focused on transforming the management of immune-mediated diseases through epiproteomics and artificial intelligence. Built on groundbreaking research from the Weizmann Institute of Science, Promise Bio analyzes proteins and their post-translational modifications (PTMs) with exceptional precision. This proprietary technology allows for large-scale PTM profiling, helping researchers uncover disease mechanisms, tailor therapies, and discover new drug targets. Their computational platform uses epiproteomics and AI to predict patient treatment responses and support drug research and development.

Funding history · 2 rounds · $9.0M total

2024-11
Seed $8.3M
★ Awz VenturesAION Labs
2023-12
Grant $700K

Headcount over time

From 6 (2023-08) to 13 (2025-12) · +7 (+117%) · 6 points · source: Finder history + radar grounding
140 2023-08 2025-12

Q&A

What is Promise Bio's primary focus?
Promise Bio is a precision medicine company focused on transforming the management of immune-mediated diseases through epiproteomics and artificial intelligence.
When was Promise Bio founded?
Promise Bio was founded in January 2023.
How much funding has Promise Bio raised in total?
Promise Bio has raised a total of $9,000,000.
Which investors participated in Promise Bio's Seed funding round in December 2024?
The Seed funding round in December 2024 included Awz Ventures.
What is the employee count for Promise Bio?
Promise Bio has 14 employees, falling within the 11-50 employee bucket.
What is the core technology behind Promise Bio's platform?
Promise Bio's platform uses proprietary Comprehensive PTM Profiling to detect up to 45 post-translational modification (PTM) types simultaneously, leveraging epiproteomics and AI.
What was the amount of the grant received by Promise Bio in January 2024?
Promise Bio received a grant of $700,000 in January 2024.
What is the latest news regarding Promise Bio's initiatives?
In February 2026, Promise Bio announced the launch of the Frontier Epiproteomic Innovation Grant, an R&D access initiative for translational epiproteomic analysis.

Team · 3

Ronel Veksler
Founder · Co-founder & CEO
Assaf Kacen
Founder · Co-founder & CTO
Yifat Merbl
Founder · Scientific Co-founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceBiologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitepromise.bio/
LinkedInlinkedin.com/company/82083896

Identifiers & details

Legal namePromise BIO Ltd.
Founded2023-1
Employees (exact)14

Radar intelligence

Open jobs — ashby

Total open17
Remote15
TitleLocationDepartment
Account Executive - Public Sector
Software Engineering Lead
Account Executive - Public Sector
Bilingual Customer Support Associate (Call Center)
Product Designer - AI
Software Engineer - AI
Software Engineer - Platform & Infrastructure
Forward Deployed Engineer
Deployment Strategist
Forward Deployed Engineer
Software Engineer - AI
Product Engineer - Frontend

Web history (Wayback)

Domainpromise.bio

Certificate / subdomain footprint

Subdomains6

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516749298
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2023-01-18
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events3 — violation (1), annual_report (2)
Registered addressהדר 3 רמת השרון

Recent registry events

DateEvent
2026-06-30עדכון הפרה
2026-06-30דו~ח שנתי-שינוי בהוראות בתקנון
2026-06-30דו~ח שנתי-עדכון מען דיגיטלי